Erlotinib 31722-0265
Product NDC
31722-0265- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 24, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA209267
Need to source Erlotinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erlotinib Hydrochloride | 150 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Packaging Options(1)
1 BOTTLE in 1 CARTON (31722-265-30) / 30 TABLET, FILM COATED in 1 BOTTLE